bpc 157 ibuprofen fatty liver hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide in rats Protecting and Repairing the Body – BPC-157: Miracle Peptide or Risky

Clinical translation would require trials in cardiac patient populations with appropriate safety monitoring given theoretical concerns about blood pressure effects and vascular remodeling

The ultra burn

While this is not a final FDA decision, its a major step forward for regenerative medicine and compounded peptides

Some compounds are identified through breakdown products that persist well beyond the parent molecule, and some testing regimes do not look for the compound at all but for biomarker patterns it produces

Over time, the body struggles to produce enough NAD+ to keep up with the energy demands and repair needs of the cells, leading to the symptoms we often associate with aging

Wouldnt that be a good thing